ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1555

18F-NaF PET/CT Identifies Active Calcium Uptake in Calcinosis Due to Dermatomyositis and Scleroderma

Carrie Richardson1, Mehrbod Javadi2, Ami Shah3, Lilja Solnes2, Fredrick Wigley4, Laura Hummers5 and Lisa Christopher-Stine6, 1Rush University Medical Center, Chicago, IL, 2Johns Hopkins University, Baltimore, 3Johns Hopkins University School of Medicine, Ellicott City, MD, 4Johns Hopkins University School of Medicine, Baltimore, MD, 5Johns Hopkins Univerisity, Ellicott City, MD, 6Johns Hopkins University, Baltimore, MD

Meeting: ACR Convergence 2020

Keywords: bone biology, dermatomyositis, Scleroderma

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 9, 2020

Session Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Ectopic soft tissue deposition of hydroxyapatite (calcinosis) is a frequent and morbid complication of dermatomyositis and scleroderma with no known effective pharmacologic treatment. 18F-NaF PET/CT detects active hydroxyapatite deposition in benign and malignant bone disorders and may identify subclinical and actively calcifying lesions in scleroderma- and dermatomyositis-related calcinosis.

Methods: In this pilot study, we enrolled three adults with dermatomyositis and three adults with scleroderma, all with new calcinosis deposits within the past six months.  Each participant underwent 18F-NaF PET/CT as well as a clinical examination for assessment of calcinosis.  We recorded the number, locations, and standardized uptake values (SUVs) of deposits for each 18F-NaF PET/CT. 

Results: 18F-NaF PET/CT detected heterogeneous uptake in calcinosis deposits appearing homogeneous on CT. 18F-NaF PET/CT also detected calcium uptake where there was no visible calcification on CT. We noted increased uptake of 18F-NaF in the axial skeleton of one patient with multiple actively calcifying deposits, consistent with increased systemic bone turnover. Some joints also demonstrated increased 18F-NaF uptake, consistent with arthritic remodeling.

Conclusion: 18F-NaF uptake on PET/CT is heterogeneous, even in radiographically homogeneous deposits, and identifies actively calcifying and subclinical deposits not apparent on CT. 18F-NaF uptake on PET/CT may be an early and sensitive marker of disease activity in calcinosis due to scleroderma and dermatomyositis.

Axial CT image in bone windows (A) demonstrates calcinosis involving the quadriceps and patellar tendon complex overlying the left patella. Axial 18F-NaF PET/CT images (B and C) demonstrate mild activity along this calcified complex (blue arrowheads). However, there is focal PET signal activity located along the semimebranosus muscle without associated calcification on CT (red arrowheads). These findings may suggest increased sensitivity of 18F-NaF PET imaging in detecting pre-calcified disease involvement.

Full-body coronal 18F-NaF PET image of Patient 6 demonstrating the distribution and intensity of 18F-NaF uptake. Note the intense activity in the upper arms and around the knees as well as widespread uptake in the thighs and pelvic girdle. There is also increased uptake in the axial skeleton, indicating increased systemic bone turnover


Disclosure: C. Richardson, None; M. Javadi, None; A. Shah, None; L. Solnes, None; F. Wigley, None; L. Hummers, Corbus Pharmaceuticals, 1, 2, Boehringer Ingelheim, 1, 2, CSL Behring, 1, 2, Cumberland Pharmaceuticals, 1, Medpace, 1, Glaxo Smith Kline, 1, Kadmon Corporation, 1; L. Christopher-Stine, None.

To cite this abstract in AMA style:

Richardson C, Javadi M, Shah A, Solnes L, Wigley F, Hummers L, Christopher-Stine L. 18F-NaF PET/CT Identifies Active Calcium Uptake in Calcinosis Due to Dermatomyositis and Scleroderma [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/18f-naf-pet-ct-identifies-active-calcium-uptake-in-calcinosis-due-to-dermatomyositis-and-scleroderma/. Accessed January 21, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/18f-naf-pet-ct-identifies-active-calcium-uptake-in-calcinosis-due-to-dermatomyositis-and-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.